hims glp 1 & Hers Stock Plummets. The Wegovy Shortage Is Over Hims offers weight loss medications,

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

In a systematic review of 55 double-blinded, placebo-controlled randomized clinical trials, GLP-1RA treatment was associated with an increased risk of cholelithiasis compared with placebo (RR 1.46, 95% CI 1.091.97) but not cholecystitis, cholangitis, or pancreatitis (63)

Metformin therapy reduces obesity indices in children and adolescents: a systematic review and meta-analysis of randomized clinical trials

Accessed 26 Apr 2019

Supplementary information Figure slide (download PPTX (PPTX 252 kb) Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made